Fig. 5

In vivo anti-inflammatory evaluation. a TNF-α level. b IL-6 level. c Total cells counts. d Neutrophils (PMNs) counts. *p < 0.05, **p < 0.01 and ***p < 0.001 indicated the indices of corresponding groups compared with ICAM/DEX/NLCs treated groups after 12 h drug administration. ^#p < 0.05, ^##p < 0.01 and ^###p < 0.001 indicated the indices of corresponding groups compared with ICAM/DEX/NLCs treated groups after 24 h drug administration. The data represent the mean ± SD (n = 6)